MC0704 is a STAT3 Inhibitor for Triple-negative Breast Cancer
4.7 (342) In stock
The novel STAT3 inhibitor WZ-2-033 causes regression of human
Ilamycin C induces apoptosis and inhibits migration and invasion
CYD-2-11 is a Selective Bax Agonist for Breast and Lung Cancer Research
Frontiers Eupalinolide J Suppresses the Growth of Triple
MC0704 is a STAT3 Inhibitor for Triple-negative Breast Cancer
Targeting CD44-STAT3 Signaling by Gemini Vitamin D Analog Leads to
MD-222 is a First-in-Class Highly Potent PROTAC Degrader of MDM2
Constitutive activation of STAT3 in breast cancer cells: A review
SD-1029 is a JAK2/STAT3 Activation Inhibitor
Life, Free Full-Text
CYD-4-61 is a Bax Activator Used for Breast Cancer Research
CCT365623, an Orally Active LOX Inhibitor, Supresses EGFR (pY1068) and AKT Phosphorylation
Zotatifin is a Selective and Well-Tolerated eIF4A (Protein Biogenesis) Inhibitor
LCH-7749944 is a Potent PAK4 Inhibitor and Induces Apoptosis
💞 Sila Star 💞 on X: Thank u all for your input yesterday! Great
Triple Negative Breast Cancer Treatment Market Overview
Triple-Negative Breast Cancer Treatment Market Size In 2024
Triple Positive Breast Cancer: Diagnosis, Treatment, and Outlook
